Cytarabine (Ara-C)
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Cytarabine (Ara-C), covering 2006-09-08 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma [Phase 2]